News

People with obesity are more likely to have a benign blood condition called monoclonal gammopathy of undetermined significance that often precedes multiple myeloma.

A novel pharmaceutical compound that kills leukemia and lymphoma cells has been identified, potentially paving the way to new forms of therapy.

Researchers have discovered that a type of immune cell in the human body known to be important for allergy and other immune responses can also attack cancer.

Researchers developed a drinkable, carbon monoxide-infused foam that boosted the effectiveness of the therapy, known as autophagy inhibition, in mice and human cells.

An extract from the Boswellia tree, which also produces frankincense, has been shown to slow breast cancer growth in an early-stage clinical trial.

A scientific team led by Christian Seiser from MedUni Vienna's Center for Anatomy and Cell Biology has now discovered a previously unrecognised control point for the repair of damage to genetic material (DNA) in the human body.

In the largest study of its kind, scientists report how combining health data with whole genome sequence (WGS) data in patients with cancer can help doctors provide more tailored care for their patients.

The "key" to making breast cancers detectable by the immune system is normally turned off to prevent excessive inflammation. Activating the key could aid cancer treatment.

Scientists have found a quick way to predict if a chemical is likely to cause breast cancer based on whether the chemical harbors specific traits.

Blood test uses cell-free DNA methylation to quantify tumor burden and distinguish neuroendocrine prostate cancer from prostate adenocarcinoma.